GT Biopharma, Inc.
GTBP
$0.43
-$0.01-1.57%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/16/2026
-
Zacks Investment Research
3/12/2026
-
Zacks Investment Research
3/11/2026
-
Globe Newswire
3/2/2026
-
TipRanks Financial Blog
3/2/2026
-
SeekingAlpha.com: All News
3/2/2026
-
Seeking Alpha - Healthcare
3/2/2026
-
The Fly
3/2/2026
-
Globe Newswire
2/17/2026
-
Globe Newswire
2/3/2026
-
The Fly
2/3/2026
-
Globe Newswire
1/17/2026
-
Ticker Report
1/16/2026
-
Globe Newswire
1/16/2026
-
CNW Group - News Releases
1/16/2026
-
PR Newswire
1/15/2026
-
Nasdaq News: Markets
1/15/2026
-
GuruFocus
1/15/2026
-
The Fly
1/15/2026
-
Globe Newswire
1/15/2026
-
Benzinga
12/24/2025
-
Globe Newswire
12/19/2025
-
CNW Group - News Releases
12/19/2025
-
PR Newswire
12/19/2025
-
PR Newswire
12/19/2025
-
CNW Group - News Releases
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 2, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
415 919 4040
Address
315 Montgomery Street
San Francisco, CA 94104
San Francisco, CA 94104
Country
Year Founded
Business Description
Sector
GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) and...
more